Serum biomarkers for the early diagnosis of TIA: The MIND-TIA study protocol
- PMID: 26215720
- PMCID: PMC4517631
- DOI: 10.1186/s12883-015-0388-z
Serum biomarkers for the early diagnosis of TIA: The MIND-TIA study protocol
Abstract
Background: A Transient Ischaemic Attack (TIA) bears a high risk of a subsequent ischaemic stroke. Adequate diagnosis of a TIA should be followed immediately by the start of appropriate preventive therapy, including antiplatelets. The diagnosis of a TIA based on symptoms and signs only is notoriously difficult and biomarkers of brain ischaemia might improve the recognition, and target management and prognosis of TIA patients. Our aim is to quantify the added diagnostic value of serum biomarkers of brain ischaemia in patients suspected of TIA.
Study design: a cross-sectional diagnostic accuracy study with an additional six month follow-up period.
Study population: 350 patients suspected of TIA in the primary care setting. Patients suspected of a TIA will be recruited by at least 200 general practitioners (GPs) in the catchment area of seven TIA outpatient clinics willing to participate in the study. In all patients a blood sample will be drawn as soon as possible after the patient has contacted the GP, but at least within 72 h after onset of symptoms. Participants will be referred by the GP to the regional TIA outpatient clinic for additional investigations, including brain imaging. The 'definite' diagnosis (reference standard) will be made by a panel consisting of three experienced neurologists who will use all available diagnostic information and the clinical information obtained during the outpatient clinic assessment, and a six month follow-up period. The diagnostic accuracy, and value in addition to signs and symptoms of candidate serum biomarkers will be assessed in terms of discrimination with C statistics, and calibration with plots. We aim to include 350 suspected cases, with 250 patients with indeed definite TIA (or minor stroke) according to the panel.
Discussion: We hope to find novel biomarkers that will enable a rapid and accurate diagnosis of TIA. This would largely improve the management and prognosis of such patients.
Trial registration: ClinicalTrials.gov Identifier NCT01954329.
Similar articles
-
Serum biomarkers in patients suspected of transient ischaemic attack in primary care: a diagnostic accuracy study.BMJ Open. 2019 Oct 17;9(10):e031774. doi: 10.1136/bmjopen-2019-031774. BMJ Open. 2019. PMID: 31628130 Free PMC article.
-
Delay in patients suspected of transient ischaemic attack: a cross-sectional study.BMJ Open. 2019 Feb 27;9(2):e027161. doi: 10.1136/bmjopen-2018-027161. BMJ Open. 2019. PMID: 30819716 Free PMC article.
-
RApid Primary care Initiation of Drug treatment for Transient Ischaemic Attack (RAPID-TIA): study protocol for a pilot randomised controlled trial.Trials. 2013 Jul 2;14:194. doi: 10.1186/1745-6215-14-194. Trials. 2013. PMID: 23819476 Free PMC article. Clinical Trial.
-
Candidate Biomarkers for the Diagnosis of Transient Ischemic Attack: A Systematic Review.Cerebrovasc Dis. 2019;47(5-6):207-216. doi: 10.1159/000502449. Epub 2019 Aug 30. Cerebrovasc Dis. 2019. PMID: 31473737 Free PMC article.
-
Preventing strokes: the assessment and management of people with transient ischaemic attack.N Z Med J. 2009 Apr 24;122(1293):3556. N Z Med J. 2009. PMID: 19448791 Review.
Cited by
-
Usefulness of EEG for the differential diagnosis of possible transient ischemic attack.Clin Neurophysiol Pract. 2017 Oct 18;3:11-19. doi: 10.1016/j.cnp.2017.10.001. eCollection 2018. Clin Neurophysiol Pract. 2017. PMID: 30215000 Free PMC article.
-
Vectorized nanodelivery systems for ischemic stroke: a concept and a need.J Nanobiotechnology. 2017 Apr 11;15(1):30. doi: 10.1186/s12951-017-0264-7. J Nanobiotechnology. 2017. PMID: 28399863 Free PMC article. Review.
-
Serum biomarkers in patients suspected of transient ischaemic attack in primary care: a diagnostic accuracy study.BMJ Open. 2019 Oct 17;9(10):e031774. doi: 10.1136/bmjopen-2019-031774. BMJ Open. 2019. PMID: 31628130 Free PMC article.
-
Diagnostic Accuracy of the Explicit Diagnostic Criteria for Transient Ischemic Attack: A Validation Study.Stroke. 2019 Aug;50(8):2080-2085. doi: 10.1161/STROKEAHA.119.025626. Epub 2019 Jun 20. Stroke. 2019. PMID: 31693449 Free PMC article.
-
Independent ischemic stroke risk factors in older Americans: a systematic review.Aging (Albany NY). 2019 May 24;11(10):3392-3407. doi: 10.18632/aging.101987. Aging (Albany NY). 2019. PMID: 31127075 Free PMC article.
References
-
- Nichols M, Townsend N, Luengo-Fernandez R, Leal J, Gray A, Scarborough P, et al. European Heart Network. Brussels, Sophia Antipolis: European Society of Cardiology; 2012.
-
- Easton JD, Saver JL, Albers GW, Alberts MJ, Chaturvedi S, Feldmann E, et al. Definition and evaluation of transient ischemic attack: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease. Stroke. 2009;40:2276–2293. doi: 10.1161/STROKEAHA.108.192218. - DOI - PubMed
-
- Rothwell PM, Giles MF, Chandratheva A, Marquardt L, Geraghty O, Redgrave JN, et al. Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparison. Lancet. 2007;370:1432–1442. doi: 10.1016/S0140-6736(07)61448-2. - DOI - PubMed
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical